These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Strategies for immunotherapy of cancer. Melief CJ; Toes RE; Medema JP; van der Burg SH; Ossendorp F; Offringa R Adv Immunol; 2000; 75():235-82. PubMed ID: 10879286 [No Abstract] [Full Text] [Related]
7. Myeloid-derived suppressor cells in cancer: recent progress and prospects. Khaled YS; Ammori BJ; Elkord E Immunol Cell Biol; 2013 Sep; 91(8):493-502. PubMed ID: 23797066 [TBL] [Abstract][Full Text] [Related]
8. Inflammation in the Tumor Microenvironment. Lin Q; Jin S; Han M; Zheng W; Liu J; Wei X J Immunol Res; 2018; 2018():1965847. PubMed ID: 30035130 [No Abstract] [Full Text] [Related]
9. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy. Baxevanis CN; Perez SA; Papamichail M Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409 [TBL] [Abstract][Full Text] [Related]
10. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How? Cancel JC; Crozat K; Dalod M; Mattiuz R Front Immunol; 2019; 10():9. PubMed ID: 30809220 [TBL] [Abstract][Full Text] [Related]
14. Targeting regulatory T cells. Ménétrier-Caux C; Curiel T; Faget J; Manuel M; Caux C; Zou W Target Oncol; 2012 Mar; 7(1):15-28. PubMed ID: 22327882 [TBL] [Abstract][Full Text] [Related]
15. Challenges and future perspectives of T cell immunotherapy in cancer. de Aquino MT; Malhotra A; Mishra MK; Shanker A Immunol Lett; 2015 Aug; 166(2):117-33. PubMed ID: 26096822 [TBL] [Abstract][Full Text] [Related]
16. Human Tumor Antigens and Cancer Immunotherapy. Vigneron N Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for pancreatic cancer: current concepts. Kaufman HL; Di Vito J; Hörig H Hematol Oncol Clin North Am; 2002 Feb; 16(1):159-97, viii. PubMed ID: 12063825 [TBL] [Abstract][Full Text] [Related]
18. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside. Braza MS; Klein B Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882 [TBL] [Abstract][Full Text] [Related]
19. The Cancer Research Institute 2013 Annual Symposium: Dynamics of host-tumor interaction. Tontonoz M; Gee CE Cancer Immunol Res; 2014 Feb; 2(2):105-11. PubMed ID: 24778274 [TBL] [Abstract][Full Text] [Related]